Do you want to know how reliable your data are?
PAASP is a global leader in the assessment and accreditation of nonclinical research practice in the field of life sciences. We provide services to facilitate the generation of robust and reliable data and enable improved and accelerated decision-making. Our mission is to increase the probability that basic nonclinical discoveries will translate into safe and effective clinical treatments.
A tool to judge risk of bias in biomedical research
Identify potential sources of bias early and improve decision-making.
START YOUR JOURNEY TO ACCREDITATION
by getting detailed information about PAASPort®
Risks in early-stage biotech investment
As the recent cases illustrate, apparent or actual issues with data integrity and research rigor can damage not only reputation of individual scientists but also affect the value of companies, whether privately held or publicly traded.
PAASP introduces a new service for the investment community engaged in early-stage biotech:
PAASPort®-based assessment of investment opportunities for data integrity and research rigor risks.
PAASP NETWORK PARTNERS ARE SUPPORTED BY
United States sponsor of the Global Preclinical Data Forum and sponsor of the Negative Data Prize and PEERS project.
A taste of our most recent headlines.
“Publication of negative/null results discussed at NIH”November 2, 2022
NINDS Office of Research Quality has presented a proposal on how to address the publication bias. It can be watched HERE (starts at…Read More
“The customer is king!”November 2, 2022
Once during our vacation in Greece, our children asked for ice cream after having dinner. When the waiter was asked about…Read More
“Hold your horses!”November 2, 2022
Risk of Alzheimer’s disease nearly doubles in older adults with Covid-19! Like many of you, several weeks ago we have also…Read More